Albany Molecular Research, Inc. (NASDAQ:AMRI) Investor Investigation of Takeover

San Diego, CA -- (SBWIRE) -- 06/14/2017 -- An investigation on behalf of investors, who currently hold shares of Albany Molecular Research, Inc. (NASDAQ:AMRI), was announced concerning whether the takeover of Albany Molecular Research, Inc. by The Carlyle Group and GTCR LLC for $21.75 per share is unfair to NASDAQ:AMRI stockholders.